AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
admin 7th February 2020 Uncategorised 0AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm.
More: AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Source: fierce